Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.57 USD | -1.49% |
|
-3.91% | -26.14% |
05/06 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
14/05 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.14% | 20Cr | |
+29.90% | 46TCr | |
+40.92% | 29TCr | |
+14.03% | 15TCr | |
+9.86% | 9.39TCr | |
+28.05% | 9.04TCr | |
+69.09% | 6.23TCr | |
+15.16% | 4.51TCr | |
+18.39% | 3.59TCr | |
+17.74% | 3.01TCr |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- Stifel Adjusts Price Target on OptimizeRx to $13 From $16, Maintains Buy Rating